GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine
Tóm tắt
Từ khóa
Tài liệu tham khảo
Orskov, 1992, Glucagon-like peptide-1, a new hormone of the entero-insular axis, Diabetologia, 35, 701, 10.1007/BF00429088
Ebert, 1980, Gastric inhibitory polypeptide, Clin. Gastroenterol., 9, 679, 10.1016/S0300-5089(21)00478-8
Adrian, 1985, Human distribution and release of a putative new gut hormone, peptide YY, Gastroenterology, 89, 1070, 10.1016/0016-5085(85)90211-2
Miyawaki, 1996, Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice, Proc. Natl. Acad. Sci. U. S. A., 96, 14843, 10.1073/pnas.96.26.14843
Scrocchi, 1996, Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene, Nat. Med., 11, 1254, 10.1038/nm1196-1254
Holst, 1999, Glucagon-like peptide-1 (GLP-1): an intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential, TEM, 10, 229
Kauth, 1987, Immunohistochemical localization of glucagon-like peptide: 1. Use of poly- and monoclonal antibodies, Histochemistry, 86, 509, 10.1007/BF00500625
Eissele, 1992, Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man, Eur. J. Clin. Invest., 22, 283, 10.1111/j.1365-2362.1992.tb01464.x
Bottcher, 1984, Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut, Regul. Pept., 8, 261, 10.1016/0167-0115(84)90034-X
Buchan, 1987, Electroimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man, Histochemistry, 56, 37, 10.1007/BF00492251
Miholic, 1991, Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1) and reactive hypoglycemia after total gastrectomy, Dig. Dis. Sci., 36, 1361, 10.1007/BF01296800
Dumoulin, 1995, Regulation of glucagon-like peptide-1 (7–36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum, Endocrinology, 136, 5182, 10.1210/en.136.11.5182
Plaisancie, 1994, Regulation of glucagon-like peptide-1 (7–36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon, Endocrinology, 135, 2398, 10.1210/en.135.6.2398
Herrmann-Rinke, 1995, Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides, J. Endocrinol., 147, 25, 10.1677/joe.0.1470025
Roberge, 1993, Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop, Endocrinology, 133, 233, 10.1210/en.133.1.233
Damholt, 1998, Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent insulinotropic peptide but unaffected by glucose, Endocrinology, 139, 2085, 10.1210/en.139.4.2085
Hansen, 2002, The effect of duodenal peptides on glucagon-like peptide-1 secretion from the ileum: a duodeno-ileal loop, Regul. Pept., 110, 39, 10.1016/S0167-0115(02)00157-X
Nauck, 1993, Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1 (7–36) amide infused at near-physiological concentrations, J. Clin. Endocrinol. Metab., 76, 912, 10.1210/jc.76.4.912
Mortensen, 2000, Colocalization of GLP-1 and GIP in human and porcine intestine, Ann. N.Y. Acad. Sci., 921, 469, 10.1111/j.1749-6632.2000.tb07017.x
Moody, 1992, The reactivity of anti-porcine gastric inhibitory polypeptide (GIP) rabbit serum R65 with synthetic human and porcine GIP, Scand. J. Clin. Lab. Invest., 52, 103, 10.3109/00365519209088772
Deacon, 2000, Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide, J. Clin. Endocrinol. Metab., 85, 3575, 10.1210/jc.85.10.3575
Orskov, 1987, Pancreatic and intestinal processing of proglucagon in man, Diabetologia, 30, 874, 10.1007/BF00274797
Bell, 1983, Hamster preproglucagon contains the sequence of glucagon and two related peptides, Nature, 302, 716, 10.1038/302716a0
Holst, 1991, Assays for peptide products of somatostatin gene expression, 3, 10.1016/B978-0-12-185259-7.50006-5
Orskov, 1991, Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine, J. Clin. Invest., 87, 415, 10.1172/JCI115012
Orskov, 1986, Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas, Endocrinology, 119, 1467, 10.1210/endo-119-4-1467
Krarup, 1984, The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera, Regul. Pept., 9, 35, 10.1016/0167-0115(84)90005-3
Damholt, 1999, Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine, Cell Tissue Res., 298, 287, 10.1007/s004419900093
Sheikh, 1989, Release of PYY from pig intestinal mucosa; luminal and neural regulation, Regul. Pept., 26, 253, 10.1016/0167-0115(89)90193-6
Lopez, 1995, Studies in transgenic mice reveal potential relationships between secretin-producing cells and other endocrine cell types, J. Biol. Chem., 270, 885, 10.1074/jbc.270.2.885
Larsson, 1975, Mixed endocrine pancreatic tumors producing several peptide hormones, Am. J. Pathol., 79, 271
Orskov, 1996, Secretion of the incretin hormones glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) correlates with insulin secretion in normal man throughout the day, Scand. J. Gastroenterol., 31, 665, 10.3109/00365529609009147
Orskov, 1987, Secretion of glicentin, glucagons-like peptide 1 and 2, neurotensin, and PYY from isolated perfused pig ileum, Front. Horm. Res. (Karger, Basel), 16, 137, 10.1159/000414304